Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib + Celecoxib vs Erlotinib in Advanced NSCLC
NCT00499655Phase 2Completed
- Sponsor
- City of Hope
- Start
- Nov 2007
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib oral solution in non-small cell lung cancer (NSCLC), sponsored by City of Hope. Started Nov 2007; status: completed.
02
Drugs
celecoxib oral solution
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00499655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00499655.